Co-treatment of nicotinamide mononucleotide and neoagarooligosaccharide mitigates aging-induced cognitive impairment by promoting mitochondrial dynamics

Co-treatment of nicotinamide mononucleotide and neoagarooligosaccharide mitigates aging-induced cognitive impairment by promoting mitochondrial dynamics

The synergistic effects of nicotinamide mononucleotide (NMN) and neoagarooligosaccharides (NAOS) on mitochondrial dysfunction, downstream apoptosis, and inflammation were evaluated in both senescence-accelerated mouse prone 8 (SAMP8) mice and H2O2-induced human lung fibroblast (MRC-5) cells. Co-trea...

Full description

Bibliographic Details
Main Authors: Tao Li, Yanxiao Li, Qiaojuan Yan, Zhengqiang Jiang, Shaoqing Yang
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Functional Foods
Subjects:
Aging
Nicotinamide mononucleotide
Neoagarooligosaccharides
Cognitive impairment
Mitochondrial dysfunction
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464623005224

Internet

http://www.sciencedirect.com/science/article/pii/S1756464623005224

Similar Items